NCT04879563

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 500 (estimated)
• Sponsor: Region Örebro County · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

ASCAPE (Artificial intelligence Supporting CAncer Patients across Europe) is a collaborative research project involving 15 partners from 7 countries, including academic medical centers, SMEs (small and medium-sized enterprises), research centers and universities, aiming to leverage the recent advances in Big Data and AI (Artificial Intelligence) to support cancer patients' Quality of Life (QoL) and health status. Specifically, ASCAPE aims to provide personalized- and AI-based predictions for QoL issues in breast- and prostate cancer patients as well as suggest potential interventions to their physicians. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 875351.

Conditions

• Breast Cancer
• Prostate Cancer
• Quality of Life
• Survivorship
• Toxicity

Interventions

Type	Name	Description
OTHER	ASCAPE-based follow-up strategy	Follow-up through ASCAPE platform including AI-based predictions for health-related QoL issues and suggestions for personalized interventions depending on the type of QoL issue that needs to be tackled. The ASCAPE-based follow-up strategy includes follow-up through validated QoL questionnaires, wearables for capturing active monitoring data, and mobile apps for answering the questionnaires and capturing potential health-related issues.

Timeline

• Start date: 2021-02-01
• Primary completion: 2024-06-30
• Completion: 2025-08-30
• First posted: 2021-05-10
• Last updated: 2024-11-19

Locations

5 sites across 4 countries: Greece, Spain, Sweden, United Kingdom